Immunosuppressants increase the levels of natural autoantibodies reactive with glycosaminoglycans in myasthenia gravis (original) (raw)
Lászlo Tóthfalusi2014, Journal of Neuroimmunology
visibility
…
description
5 pages
link
1 file
Related papers
Clinical and biological heterogeneity of autoimmune myasthenia gravis
Journal of Neuroimmunology, 2011
Clinical features of patients with myasthenia gravis associated with autoimmune diseases
European Journal of Neurology, 2007
?-Bungarotoxin sensitization in experimental autoimmune myasthenia gravis
Muscle & Nerve, 1993
Association Between Myasthenia Gravis and Systemic Lupus Erythematosus as a Comorbid State
Cureus, 2021
Mild Clinical Expression of Myasthenia Gravis Associated with Autoimmune Thyroid Diseases 1
The Journal of Clinical Endocrinology & Metabolism, 1997
Familial autoimmune myasthenia gravis: report of four families
Journal of Neurology, Neurosurgery & Psychiatry, 1995
JCI Insight, 2019
Acetylcholine receptor gene expression in experimental autoimmune myasthenia gravis
FEBS Letters, 1990
Long-term effects of combined immunosuppressive treatment on myasthenic crisis
European Journal of Neurology, 2009
Specific immunotherapy of experimental myasthenia gravis by a novel mechanism
Annals of Neurology, 2009
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.
Related papers
2019
FEBS Letters, 1988
Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis
Arthritis Research & Therapy, 2008
A candidate gene for autoimmune myasthenia gravis
Neurology, 2012
Intravenous Immunoglobulin for the Treatment of Acquired Myasthenia Gravis
Neurology, 1998
Myasthenia Gravis and Autoimunne Thyroid Disease Association
Haydarpasa Numune Training and Research Hospital Medical Journal, 2019
Complement Inhibitor Therapy for Myasthenia Gravis
Frontiers in Immunology, 2020
Autoantibodies in acquired myasthenia gravis: Clinical phenotype and immunological correlation
Acta Neurologica Scandinavica, 2019
Myasthenia Gravis Development and Crisis Subsequent to Multiple Sclerosis
Case Reports in Medicine, 2011
Autoimmune diseases - New insights into a troublesome field
Journal of Translational Autoimmunity, 2021
Resolution of Autoimmune Oophoritis after Thymectomy in a Myasthenia Gravis Patient
J Clin Res Pediatr En …, 2011
Effectiveness of immunotherapy in myasthenia gravis: epidemiological evidence from Sri Lanka
Neurology Asia, 2005
Biomarker development for myasthenia gravis
Annals of the New York Academy of Sciences, 2012
International consensus guidance for management of myasthenia gravis
Neurology, 2016
Myasthenia Gravis: Diagnosis and Treatment
Journal of the American Academy of Nurse Practitioners, 2003
Etiology of myasthenia gravis: Innate immunity signature in pathological thymus
Autoimmunity Reviews, 2013
Recommendations for myasthenia gravis clinical trials
Muscle & Nerve, 2013
Associated autoimmune diseases in myasthenia gravis A population-based study
Acta Neurologica Scandinavica, 2009
Complicating autoimmune diseases in myasthenia gravis: a review
Autoimmunity, 2015
Changes in inflammatory cytokine networks in myasthenia gravis
Scientific Reports, 2016
Advances in autoimmune myasthenia gravis management
Expert Review of Neurotherapeutics, 2018
Clinical Use of Immunosuppressants
Textbook of Critical Care, 2011
Diagnosis and Management of Autoimmune Myasthenia Gravis
2011
Neuroscience & Biobehavioral Reviews, 2014
Consistent improvement with eculizumab across muscle groups in myasthenia gravis
Annals of Clinical and Translational Neurology, 2020
Related topics
ImmunologyAutoimmunityMedicineNeuroimmunologyGlycosaminoglycanGlycosylationGlycosaminoglycansAntibodyMicroarray AnalysisMyasthenia GravisAnalysis of VarianceNeurosciencesEnzyme Linked Immunosorbent AssayAutoantibodiesImmunosuppressive Agents